ADHD Epidemiology Overview and Insights Report 2018 - ResearchAndMarkets.com

DUBLIN--()--The "ADHD: Epidemiology Overview and Insights" report has been added to ResearchAndMarkets.com's offering.

ADHD: Epidemiology Overview and Insights report delivers an in-depth understanding of the disease and the historical & forecasted epidemiology of ADHD disease in terms of diagnosed prevalent and the treated patients in the US, EU5 (Germany, France, Italy, Spain, UK), and Japan market till 2024. The epidemiology numbers in the report have been derived based on numerous studies, survey reports and views of key opinion leaders.

Key Topics Covered:

1 Table & Figures

2 Executive Summary

2.1 Key Metrics

3 Disease Overview

3.1 Disease Definition

3.2 Disease Etiology and Pathophysiology

3.2.1 Etiology

3.2.2 Pathophysiology

3.2.3 Impact on Quality of Life

3.3 Symptoms of the Disease

3.4 Disease Diagnosis

3.5 Treatment Guidelines

3.6 Key unmet needs

4 Disease Epidemiology

4.1 Diagnosed Prevalent Patient projections by Country (Forecast till 2024)

4.2 Treated Patient projections by Country (Forecast till 2024)

5 Appendix

Companies Mentioned

  • Shionogi
  • Shire
  • Supernus Pharmaceuticals
  • Yale University
  • Chugai Pharmaceutical
  • Eli Lilly
  • GlaxoSmithKline
  • New River Pharmaceuticals
  • Johnson & Johnson
  • Celgene
  • Elan
  • Novartis
  • Teva Pharmaceutical Industries
  • Cephalon
  • Alkermes
  • Recro Pharma
  • Neos Therapeutics
  • Afecta Pharmaceuticals
  • Sumitomo Dainippon Pharma
  • Sepracor
  • Aquestive Therapeutics
  • KemPharm

For more information about this report visit https://www.researchandmarkets.com/research/npd253/adhd_epidemiology?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs